Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren and furosemide interaction study in patients with heart failure
2008-006156-22Phase 2Completed
- Sponsor
- Novartis
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of aliskiren and furosemide in heart failure (HF) (3 arms), sponsored by Novartis. Primary endpoints: Urinary sodium concentration and Diuretic efficacy. Started Jan 2010; status: completed.
02
Drugs
aliskirenfurosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2008-006156-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006156-22.